Results 1 to 10 of about 14,948 (182)

Ghrelin alleviates 6-hydroxydopamine-induced neurotoxicity in SH-SY5Y cells [PDF]

open access: yesNeural Regeneration Research, 2022
Ghrelin is a neuropeptide that has various physiological functions and has been demonstrated to be neuroprotective in a number of neurological disease models. However, the underlying mechanisms of ghrelin in Parkinson’s disease remain largely unexplored.
Xin He   +6 more
doaj   +2 more sources

The c-Abl/p73 pathway induces neurodegeneration in a Parkinson's disease model

open access: yesIBRO Neuroscience Reports, 2022
Parkinson's disease is the second most common neurodegenerative disorder. Although it is clear that dopaminergic neurons degenerate, the underlying molecular mechanisms are still unknown, and thus, successful treatment is still elusive. One pro-apoptotic
Tamara Marín   +7 more
doaj   +1 more source

The pre-teatment effect of voluntary exercise by GDNF on lesion injectioned by 6- hydroxydopamine in brain stem of male rats Abstract [PDF]

open access: yesفیزیولوژی ورزش و فعالیت بدنی, 2014
Background&Purpose: The purpose of this research was to investigate the protective effect of voluntary exercise by GDNF on lesion induced by 6-hydroxydopamine in brainstem of male rats.
راضیه محمدی   +3 more
doaj   +1 more source

Dose-Dependent Effect of Flouxetine on 6-OHDA-Induced Catalepsy in Male Rats: A Possible Involvement of 5-HT1A Receptors [PDF]

open access: yesAdvanced Pharmaceutical Bulletin, 2013
Purpose: Progressive loss of dopaminergic neurons of the substantia nigra pars compacta (SNc) in Parkinson’s disease (PD) leads to impairment of motor skills. Several evidences show that the role of serotonergic system in regulation of normal movement is
Safar Farajnia   +2 more
doaj   +1 more source

Protective Effect of Amber Extract on Human Dopaminergic Cells against 6-Hydroxydopamine-Induced Neurotoxicity

open access: yesMolecules, 2022
Parkinson’s disease (PD) is the second most common progressive neurodegenerative disease, after Alzheimer’s disease. In our previous study, we found that amber—a fossilized plant resin—can protect cells from apoptosis by decreasing the generation of ...
Yuening Luo   +5 more
doaj   +1 more source

Simvastatin prevents dopaminergic neurodegeneration in experimental parkinsonian models: the association with anti-inflammatory responses.

open access: yesPLoS ONE, 2011
BackgroundIn addition to their original applications to lowering cholesterol, statins display multiple neuroprotective effects. N-methyl-D-aspartate (NMDA) receptors interact closely with the dopaminergic system and are strongly implicated in therapeutic
Junqiang Yan   +12 more
doaj   +1 more source

Protective effect of tetrahydroxystilbene glucoside on 6-OHDA-induced apoptosis in PC12 cells through the ROS-NO pathway. [PDF]

open access: yesPLoS ONE, 2011
Oxidative stress plays an important role in the pathogenesis of neurodegenerative diseases, such as Parkinson's disease. The molecule, 2,3,5,4'-tetrahydr- oxystilbene-2-O-β-D-glucoside (TSG), is a potent antioxidant derived from the Chinese herb ...
Lizhen Tao   +9 more
doaj   +1 more source

Differences in brain pathological changes between rotenone and 6-hydroxydopamine Parkinson’s disease models

open access: yesNeural Regeneration Research, 2018
Rotenone and 6-hydroxydopamine are two drugs commonly used to generate Parkinson’s disease animal models. They not only achieve degenerative changes of dopaminergic neurons in the substantia nigra, but also satisfy the requirements for iron deposition ...
Lan-Xiang Liu   +9 more
doaj   +1 more source

Effects of Neonatal Treatment With 6-Hydroxydopamine and Endocrine Disruptors on Motor Activity and Gene Expression in Rats

open access: yesNeural Plasticity, 2004
To investigate the mechanisms underlying motor hyperactivity, we performed intracisternal injection of 6-hydroxydopamine or endocrine disruptors in rats on postnatal day 5. 6-Hydroxydopamine (100 μg, 488 nmol) caused a significant increase in spontaneous
Yoshinori Masuo   +3 more
doaj   +1 more source

Dopaminergic neurons show increased low-molecular-mass protein 7 activity induced by 6-hydroxydopamine in vitro and in vivo

open access: yesTranslational Neurodegeneration, 2018
Background Abnormal expression of major histocompatibility complex class I (MHC-I) is increased in dopaminergic (DA) neurons in the substantia nigra (SN) in Parkinson’s disease (PD).
Ming-Shu Mo   +13 more
doaj   +1 more source

Home - About - Disclaimer - Privacy